Post X-Waiver Substance Use Disorder Training Module 5: Effective Treatment Planning

Description

Register now for this online, self-guided course!

This module will discuss how to effectively plan SUD treatment options for individualized patients. It will also help educate participants on when and how to refer to higher levels of care, and how to follow up with patients for chronic pain and SUD. This will include understanding of stigma and bias faced by patients with OUD and how to effectively treat patients with compassion and non-judgment. Lastly, it will discuss the legal and ethical issues surrounding SUD care including the NC STOP Act, ADA protections for people with SUD, federal privacy laws (42 CFR), and naloxone prescribing.

Approximate time to complete the course: 1 hour
Learner content includes: video and corresponding course handouts
Participants have unlimited time to complete this course and access course materials

This training module is part of a training suite that has been developed in accordance with the recommendations from the DEA and SAMHSA for the Medication Access and Training Expansion (MATE) Act. This requirement applies to physicians, physician assistants, nurse practitioners, podiatrists, dentists, and other practitioners that prescribe controlled substances who are applying for or renewing their DEA license after June 27, 2023.

Click here for more information and a full listing of modules available.


MAHEC engages in evaluation activities to better understand the impact of our programs. By registering for this course, you agree that we may use your personal information in evaluative research regarding this program. Any reports published will be de-identified and reported in aggregate format.

With Support From

Target Audience

This program is recommended for physicians, physician assistants, nurse practitioners, podiatrists, dentists, and other practitioners that prescribe controlled substances.

Objectives

• Demonstrate comfort collaborating with other disciplines to ensure access to medications and referrals to services
• Practice planning for referral and follow-up for pain and SUD
• Examine the history of stigma and bias patients with OUD have faced and demonstrate compassionate, non-judgemental and effective care
• Examine the legal and ethical issues surrounding SUD care, including the NC STOP Act, ADA protections for people with OUD, SUD federal privacy laws, and naloxone prescribing

Faculty

• Blake Fagan, MD